MIRM Reports 2.72-Point Pruritus Improvement, 1.64-Point Placebo Difference, 55.6% ≥2-Point Reduction, FDA Meeting Set for Summer 2026
Mirum Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $96.33
+3.2% in 7d after detection
Post-detection moves
1h
—
1d
+0.0%
3d
-2.7%
7d
+3.2%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS